frank w. moler, md, ms

Professor, Department of Pediatrics and Communicable Diseases
Division of Pediatric Critical Care Medicine

734-764-5302
fmoler@umich.edu

Dr. Moler is Professor of Pediatrics and Communicable Diseases in the Division of Pediatric Critical Care Medicine.  He received his MD degree from the University of Michigan Medical School and completed his residency in Pediatrics and fellowship training in Pediatric Critical Care also at the University of Michigan. Upon completing his fellowship training, he remained on faculty at the University of Michigan C.S. Mott Children’s Hospital. Dr. Moler completed a M.S. degree in Clinical Research Design and Statistical Analysis from the University of Michigan School of Public Health.

Dr. Moler’s research interests focus on multicenter clinical research studies related to pediatric critical care medicine. Areas of current and past expertise include cardiac arrest, therapeutic hypothermia, severe cardiac and respiratory failure requiring rescue therapies, inhaled and intravenous beta 2 agonists, asthma, bronchiolitis and severity of illness outcome modeling. He is currently an active member of two federally funded pediatric clinical research networks Pediatric Emergency Care Applied Research Network (PECARN) and Collaborative Pediatric Critical Care Research Network (CPCCRN)

Dr. Moler’s current research support is with NHLBI, NICHD and HRSA.   He is the overall PI of the multicenter NHLBI funded THAPCA Trials being conducted at 38 sites in the US and Canada. THAPCA is investigating the efficacy of therapeutic hypothermia for pediatric cardiac arrest by way of two separate trials in the in-hospital and out-of-hospital settings. He is also a co-PI on a NIH planning grant for an efficacy trial of therapeutic hypothermia for hyperammonemia associated with metabolic disease RCT, and a co-investigator in a NHLBI study that is investigating the pharmacokinetics of morphine and midazolam following pediatric cardiac arrest and therapeutic hypothermia.